1. Home
  2. APYX vs NERV Comparison

APYX vs NERV Comparison

Compare APYX & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apyx Medical Corporation

APYX

Apyx Medical Corporation

HOLD

Current Price

$3.10

Market Cap

196.4M

Sector

Health Care

ML Signal

HOLD

Logo Minerva Neurosciences Inc

NERV

Minerva Neurosciences Inc

HOLD

Current Price

$4.89

Market Cap

231.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APYX
NERV
Founded
1982
2007
Country
United States
United States
Employees
N/A
7
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
196.4M
231.1M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
APYX
NERV
Price
$3.10
$4.89
Analyst Decision
Strong Buy
Buy
Analyst Count
4
2
Target Price
$6.50
$10.50
AVG Volume (30 Days)
153.1K
131.9K
Earning Date
05-07-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
19.40
N/A
EPS
N/A
N/A
Revenue
N/A
$41,175,600.00
Revenue This Year
$11.93
N/A
Revenue Next Year
$11.01
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.70
$1.93
52 Week High
$5.08
$12.46

Technical Indicators

Market Signals
Indicator
APYX
NERV
Relative Strength Index (RSI) 37.26 59.74
Support Level $2.83 $5.02
Resistance Level $3.29 $5.73
Average True Range (ATR) 0.21 0.35
MACD 0.01 0.10
Stochastic Oscillator 41.04 71.23

Price Performance

Historical Comparison
APYX
NERV

About APYX Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

Share on Social Networks: